| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129
The single biggest challenge facing in vivo imaging techniques is to develop biocompatible molecular beacons that are capable of specifically and accurately measuring in vivo targets at the protein, RNA, or DNA level. Our efforts have focused on developing activatable imaging probes to measure specific enzyme activities in vivo. Using cathepsin D as a model target protease, we synthesized a long-circulating, synthetic graft copolymer bearing near-infrared (NIR) fluorochromes positioned on cleavable substrate sequences. In its native state, the reporter probe was essentially nonfluorescent at 700 nm due to energy resonance transfer among the bound fluorochromes (quenching) but became brightly fluorescent when the latter were released by cathepsin D. NIR fluorescence signal activation was linear over at least 4 orders of magnitude and specific when compared with scrambled nonsense substrates. Using matched rodent tumor models implanted into nude mice expressing or lacking the targeted protease, it could be shown that the former generated sufficient NIR signal to be directly detectable and that the signal was significantly different compared with negative control tumors. The developed probes should find widespread applications for real-time in vivo imaging of a variety of clinically relevant proteases, for example, to detect endogenous protease activity in disease, to monitor the efficacy of protease inhibitors, or to image transgene expression.
This article has been cited by other articles:
|
|
 |
|
  Y. Hama, Y. Urano, Y. Koyama, A. J. Gunn, P. L. Choyke, and H. Kobayashi A Self-Quenched Galactosamine-Serum Albumin-RhodamineX Conjugate: A "Smart" Fluorescent Molecular Imaging Probe Synthesized with Clinically Applicable Material for Detecting Peritoneal Ovarian Cancer Metastases Clin. Cancer Res., November 1, 2007; 13(21): 6335 - 6343. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Alencar, M. A. Funovics, J. Figueiredo, H. Sawaya, R. Weissleder, and U. Mahmood Colonic Adenocarcinomas: Near-Infrared Microcatheter Imaging of Smart Probes for Early Detection--Study in Mice Radiology, July 1, 2007; 244(1): 232 - 238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Hama, Y. Urano, Y. Koyama, M. Kamiya, M. Bernardo, R. S. Paik, I. S. Shin, C. H. Paik, P. L. Choyke, and H. Kobayashi A Target Cell-Specific Activatable Fluorescence Probe for In vivo Molecular Imaging of Cancer Based on a Self-Quenched Avidin-Rhodamine Conjugate Cancer Res., March 15, 2007; 67(6): 2791 - 2799. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-o Deguchi, M. Aikawa, C.-H. Tung, E. Aikawa, D.-E. Kim, V. Ntziachristos, R. Weissleder, and P. Libby Inflammation in Atherosclerosis: Visualizing Matrix Metalloproteinase Action in Macrophages In Vivo Circulation, July 4, 2006; 114(1): 55 - 62. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Grimm, D. G. Kirsch, S. D. Windsor, C. F. B. Kim, P. M. Santiago, V. Ntziachristos, T. Jacks, and R. Weissleder Use of gene expression profiling to direct in vivo molecular imaging of lung cancer PNAS, October 4, 2005; 102(40): 14404 - 14409. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. A. Jaffer and R. Weissleder Molecular Imaging in the Clinical Arena JAMA, February 16, 2005; 293(7): 855 - 862. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.F.B. KIM, E.L. JACKSON, D.G. KIRSCH, J. GRIMM, A.T. SHAW, K. LANE, J. KISSIL, K.P. OLIVE, A. SWEET-CORDERO, R. WEISSLEDER, et al. Mouse Models of Human Non-Small-Cell Lung Cancer: Raising the Bar Cold Spring Harb Symp Quant Biol, January 1, 2005; 70(0): 241 - 250. [Abstract] [PDF]
|
|
|
|
|
|
C. S. Gondi, S. S. Lakka, N. Yanamandra, W. C. Olivero, D. H. Dinh, M. Gujrati, C. H. Tung, R. Weissleder, and J. S. Rao Adenovirus-Mediated Expression of Antisense Urokinase Plasminogen Activator Receptor and Antisense Cathepsin B Inhibits Tumor Growth, Invasion, and Angiogenesis in Gliomas Cancer Res., June 15, 2004; 64(12): 4069 - 4077. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Funovics, R. Weissleder, and U. Mahmood Catheter-based in Vivo Imaging of Enzyme Activity and Gene Expression: Feasibility Study in Mice Radiology, June 1, 2004; 231(3): 659 - 666. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Citrin, A. K. Lee, T. Scott, M. Sproull, C. Menard, P. J. Tofilon, and K. Camphausen In vivo tumor imaging in mice with near-infrared labeled endostatin Mol. Cancer Ther., April 1, 2004; 3(4): 481 - 488. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Moore, Z. Medarova, A. Potthast, and G. Dai In Vivo Targeting of Underglycosylated MUC-1 Tumor Antigen Using a Multimodal Imaging Probe Cancer Res., March 1, 2004; 64(5): 1821 - 1827. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Shah, C.-H. Tung, C.-H. Chang, E. Slootweg, T. O'Loughlin, X. O. Breakefield, and R. Weissleder In Vivo Imaging of HIV Protease Activity in Amplicon Vector-transduced Gliomas Cancer Res., January 1, 2004; 64(1): 273 - 278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ke, X. Wen, M. Gurfinkel, C. Charnsangavej, S. Wallace, E. M. Sevick-Muraca, and C. Li Near-Infrared Optical Imaging of Epidermal Growth Factor Receptor in Breast Cancer Xenografts Cancer Res., November 15, 2003; 63(22): 7870 - 7875. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Mahmood and R. Weissleder Near-Infrared Optical Imaging of Proteases in Cancer Mol. Cancer Ther., May 1, 2003; 2(5): 489 - 496. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. F. Massoud and S. S. Gambhir Molecular imaging in living subjects: seeing fundamental biological processes in a new light Genes & Dev., March 1, 2003; 17(5): 545 - 580. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Tsourkas, M. A. Behlke, S. D. Rose, and G. Bao Hybridization kinetics and thermodynamics of molecular beacons Nucleic Acids Res., February 15, 2003; 31(4): 1319 - 1330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Laxman, D. E. Hall, M. S. Bhojani, D. A. Hamstra, T. L. Chenevert, B. D. Ross, and A. Rehemtulla Noninvasive real-time imaging of apoptosis PNAS, December 24, 2002; 99(26): 16551 - 16555. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. A. Jaffer, C.-H. Tung, R. E. Gerszten, and R. Weissleder In Vivo Imaging of Thrombin Activity in Experimental Thrombi With Thrombin-Sensitive Near-Infrared Molecular Probe Arterioscler Thromb Vasc Biol, November 1, 2002; 22(11): 1929 - 1935. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Tefferi, E. D. Wieben, G. W. Dewald, D. A. H. Whiteman, M. E. Bernard, and T. C. Spelsberg Primer on Medical Genomics Part II: Background Principles and Methods in Molecular Genetics Mayo Clin. Proc., August 1, 2002; 77(8): 785 - 808. [Abstract] [PDF]
|
|
|
|
|
|
U. Mahmood, C.-H. Tung, Y. Tang, and R. Weissleder Feasibility of in Vivo Multichannel Optical Imaging of Gene Expression: Experimental Study in Mice Radiology, August 1, 2002; 224(2): 446 - 451. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Chen, C.-H. Tung, U. Mahmood, V. Ntziachristos, R. Gyurko, M. C. Fishman, P. L. Huang, and R. Weissleder In Vivo Imaging of Proteolytic Activity in Atherosclerosis Circulation, June 11, 2002; 105(23): 2766 - 2771. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Ghigo, C. Capo, M. Aurouze, C.-H. Tung, J.-P. Gorvel, D. Raoult, and J.-L. Mege Survival of Tropheryma whipplei, the Agent of Whipple's Disease, Requires Phagosome Acidification Infect. Immun., March 1, 2002; 70(3): 1501 - 1506. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Baler Clockless Yeast and the Gears of the Clock: How Do They Mesh? J Biol Rhythms, December 1, 2001; 16(6): 516 - 522. [Abstract] [PDF]
|
|
|
|
|
|
A. Moore, L. Josephson, R. M. Bhorade, J. P. Basilion, and R. Weissleder Human Transferrin Receptor Gene as a Marker Gene for MR Imaging Radiology, October 1, 2001; 221(1): 244 - 250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Weissleder and U. Mahmood Molecular Imaging Radiology, May 1, 2001; 219(2): 316 - 333. [Abstract] [Full Text]
|
|
|
|
|
|
C. M. C. Tempany and B. J. McNeil Advances in Biomedical Imaging JAMA, February 7, 2001; 285(5): 562 - 567. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Bremer, S. Bredow, U. Mahmood, R. Weissleder, and C.-H. Tung Optical Imaging of Matrix Metalloproteinase-2 Activity in Tumors: Feasibility Study in a Mouse Model Radiology, November 1, 2001; 221(2): 523 - 529. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Bremer, C.-H. Tung, A. Bogdanov Jr, and R. Weissleder Imaging of Differential Protease Expression in Breast Cancers for Detection of Aggressive Tumor Phenotypes Radiology, March 1, 2002; 222(3): 814 - 818. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
